Tamoxifen and Anastrozole are both used for breast cancer treatment and risk reduction, but they differ on onset, duration and tolerability. Here is the practical comparison.
Tamoxifen vs Anastrozole
| Factor | Tamoxifen | Anastrozole |
|---|---|---|
| Class | selective oestrogen receptor modulator | Same therapeutic goal, different pharmacokinetics |
| Onset | biological effect immediate; recurrence benefit accrues over years | Comparable or slower depending on formulation |
| Duration | 24-hour dosing | Differs: the main reason clinicians switch |
| Strengths | 10 mg, 20 mg | Separate titration ladder |
| Typical tolerability issue | hot flushes | Class-typical, usually mild |
| Generic availability | Widely available from GMP manufacturers | Widely available |
Key takeaways
- Choose Tamoxifen when the priority is steady, sustained cover.
- Choose Anastrozole when tolerability or dosing convenience matters more.
- Both are available as quality generics, so cost is rarely the deciding factor.
- Switching within class does not usually require a washout period.
Which patient suits which
Patients who want on-demand control and a short exposure window generally do better on Tamoxifen. Those who prefer fewer decision points, or who did not tolerate the first option, usually move to Anastrozole. Both are prescribed for breast cancer treatment and risk reduction and both need the same contraindication check: history of VTE or endometrial carcinoma without specialist review.
Supply-side view
For pharmacies and telehealth platforms, stocking both gives prescribers a switch option without a re-order delay. ShiningRX ships Tamoxifen and Anastrozole together on one consignment to reduce freight cost per unit.
Tamoxifen at a glance
| Attribute | Detail |
|---|---|
| Drug class | selective oestrogen receptor modulator |
| Common brand | Nolvadex |
| Licensed use | breast cancer treatment and risk reduction |
| Available strengths | 10 mg, 20 mg |
| Dosage form | film-coated tablet |
| Typical onset | biological effect immediate; recurrence benefit accrues over years |
| Duration / dosing interval | 24-hour dosing |
| Storage | below 30 °C, protect from light |